Delivery Order SPE2DB22D3019-SPE2DB24FK3NK
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TESTOSTERONE 1% (25MG/2.5G) PK 2.5GM to the Defense Logistics Agency (DLA), a defense agency. The $1,296.00 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 23, 2025, with a completion date of May 27, 2025. This delivery order contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D2005|SPE2DB24FJRF9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,036.98, is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical product. This contract does not have a set-aside designation and has an ultimate completion date of August 14, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded multiple federal...
This federal contract award, valued at $1,944.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of testosterone 1% (25mg/2.5g) medication, with a completion date of May 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FZ2D5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of testosterone 1% (50 mg/5 g) pharmaceutical product, with a ceiling value of $2,715.46 and a completion date of March 3, 2025. This is a firm fixed-price delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,376.10, to provide the product "Testosterone 1% (25mg/2.5g) PK 2.5gm". The contract has a completion date of June 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,132.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Testosterone 1% (25mg/2.5g) pharmaceutical products. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of Testosterone 1% (50 mg/5 g) pharmaceutical products to the Defense Logistics Agency (DLA). The $3,132.72 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award, with ID SPE2DB22D3019|SPE2DB25FK3BD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,405.70, is a Firm Fixed Price Delivery Order for the supply of Testosterone 1% (50 mg/5 g) in packs of 5 grams. This contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,578.49 firm fixed-price delivery order is for the supply of 4568196920 - Testosterone 1% (25mg/2.5g) PK 2.5gm pharmaceutical products. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This award is associated...
This federal contract award is for the delivery of Testosterone 1% (25mg/2.5g) packaged in individual units. The contract, valued at $1,117.08, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 6, 2024. It is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen will provide this testosterone medication product to support the healthcare needs...